Diabetes Management Company with 161% Jump in Sequential Quarterly Revenues – Look at DRIO
Take a Look at LabStyle Innovations Corp.
A Comprehensive Digital Glucose Measurement and Disease Management Tool Set that Improved the Lives of People with and at Risk for Diabetes.
Key Investor Points:
• Dario provides a proprietary smartphone-based platform for comprehensive diabetes management with iOS and Android compatibility.
• Dario has Proven Usability and High Accuracy coupled with coaching, feedback and predictive analytics delivers significant benefits to patients and HC systems.
• Growing list of accessible markets via CE Mark, Health Canada, Australia TGA with expected FDA clearance in 2015.
• Business model delivers multiple recurring revenue drivers.
Latest news on DRIO:
• 161% jump in sequential quarterly revenues in Q2-15
• 77% increase in shipments to distributors and customers in Q2-15 over Q1-15
• Dario launches in Canada with reimbursement from majority health plans
• U.S. General Manager appointed in anticipation of FDA clearance in the coming months
Management Objectives moving ahead:
• Continuing revenue growth momentum from Dario product and software sales to current and new customers
• U.S. market launch expected in the coming months following anticipated FDA clearance for the Dario; U.S. is largest addressable market in the world
• Market launches expected in additional strategic territories
• Pursuing regulatory approval and reimbursement in additional markets
• Signing additional strategic deals with healthcare providers and HMOs to monetize cloud-based data services
• Continuous improvement of margins via volume-driven cost reductions
Company Name: PublicWire
Contact Person: Dave Donlin
Address:5850 TG Lee Blvd, Suite 300
Country: United States